Stockreport

LENZ Therapeutics to Participate in Upcoming Investor Conferences

LENZ Therapeutics, Inc.  (LENZ) 
PDF SAN DIEGO, Nov. 12, 2024 (GLOBE NEWSWIRE) -- LENZ Therapeutics, Inc. (Nasdaq: LENZ or “LENZ” or the “Company”), a pre-commercial stage biopharmaceutical company focuse [Read more]